ir.contravir.com
ContraVir Pharmaceuticals Enrolls First Patient in Pivotal Phase 3 Study of FV-100 for Treatment of Shingles and Shingles-Associated Pain - Aug 3, 2015
http://ir.contravir.com/2015-08-03-ContraVir-Pharmaceuticals-Enrolls-First-Patient-in-Pivotal-Phase-3-Study-of-FV-100-for-Treatment-of-Shingles-and-Shingles-Associated-Pain
Press enter to begin your search. ContraVir Pharmaceuticals Enrolls First Patient in Pivotal Phase 3 Study of FV-100 for Treatment of Shingles and Shingles-Associated Pain. EDISON, N.J. Aug 3, 2015. The study will build upon prior clinical results for FV-100, including Phase 1 trials and a large Phase 2 clinical trial in shingles patients, which demonstrated favorable safety and tolerability for FV-100. The pivotal study 007 will compare FV-100 to valacyclovir (Valtrex. MD, Ph.D., the primary inv...Herpe...
ir.contravir.com
Investors | ContraVir Pharmaceuticals - Get News Alerts by Email
http://ir.contravir.com/get-news-alerts-by-email
Press enter to begin your search. Get News Alerts by Email. Click here to unsubscribe). Daily Closing Stock Price. End of Week Stock Price Summary. Proxy and Information Statements. ContraVir Pharmaceuticals, Inc. 399 Thornall Street, 1st Floor. Edison, NJ 08837. Oct 24, 2016. ContraVir to Present at the Sidoti and Company Fall 2016 Emerging Growth Convention. Oct 17, 2016. CMX157 Advances Head-to-Head Phase 2a Clinical Study in Hepatitis B Patients with Favorable Recommendation from DSMB. Oct 13, 2016.
ir.contravir.com
ContraVir to Present at Cantor Fitzgerald Inaugural Healthcare Conference - Jul 1, 2015
http://ir.contravir.com/2015-07-01-ContraVir-to-Present-at-Cantor-Fitzgerald-Inaugural-Healthcare-Conference
Press enter to begin your search. ContraVir to Present at Cantor Fitzgerald Inaugural Healthcare Conference. EDISON, N.J. July 1, 2015. ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that it will present at the Cantor Fitzgerald Inaugural Healthcare Conference taking place in New York, NY. On July 8, 2015. At Le Parker Meridien Hotel. Wednesday, July 8, 2015. ContraVir is a bioph...
ir.contravir.com
Financial Information | ContraVir Pharmaceuticals
http://ir.contravir.com/financial-information
Press enter to begin your search. Select the financial statements you wish to view below. The reports below may be viewed on either an annual or quarterly basis. All numbers in thousands USD. Jun 30, 2016. Jun 30, 2015. Jun 30, 2014. Jun 30, 2013. Selling General and Administrative. Operating Income or Loss. Income from Continuing Operations. Total Other Income/Expenses Net. Earnings Before Interest And Taxes. Net Income From Continuing Ops. Effect Of Accounting Changes. ContraVir Pharmaceuticals, Inc.
ir.contravir.com
Company Information | ContraVir Pharmaceuticals
http://ir.contravir.com/overview
Press enter to begin your search. Aug 22, 2016. ContraVir to Release New CRV431 Data Highlighting Potential Synergy with CMX157 Against Hepatitis B. Aug 2, 2016. ContraVir Reports Positive Data from Phase 1b Study of CMX157; Head-to-Head Phase 2a Study vs. Viread Ongoing in Hepatitis B Patients. Jul 28, 2016. ContraVir Pharmaceuticals to Present at the 2016 Canaccord Genuity Growth Conference. No events to display. ContraVir Pharmaceuticals, Inc. 399 Thornall Street, 1st Floor. Edison, NJ 08837. ContraVi...
ir.contravir.com
Stock Information | ContraVir Pharmaceuticals
http://ir.contravir.com/stock-information
Press enter to begin your search. 112 - $1.20. 076 - $6.28. Quote data delayed by at least 15 minutes. ContraVir Pharmaceuticals, Inc. 399 Thornall Street, 1st Floor. Edison, NJ 08837. Get Important News and Updates by Email. Aug 22, 2016. ContraVir to Release New CRV431 Data Highlighting Potential Synergy with CMX157 Against Hepatitis B. Aug 2, 2016. ContraVir Reports Positive Data from Phase 1b Study of CMX157; Head-to-Head Phase 2a Study vs. Viread Ongoing in Hepatitis B Patients. Jul 28, 2016.
ir.contravir.com
SEC Filings | ContraVir Pharmaceuticals
http://ir.contravir.com/SEC-filings
Press enter to begin your search. Select the filing type and date range you wish to view from the drop-down menus below. Proxy and Information Statements. Amendment to a previously filed 8-K. Aug 22, 2016. Report of unscheduled material events or corporate event. Aug 22, 2016. Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions. Aug 17, 2016. Aug 17, 2016. Aug 9, 2016. Aug 2, 2016. Jul 20, 2016. Report of...
ir.contravir.com
News Releases | ContraVir Pharmaceuticals
http://ir.contravir.com/news-releases
Press enter to begin your search. These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below. Get News Alerts by Email. Aug 22, 2016. ContraVir to Release New CRV431 Data Highlighting Potential Synergy with CMX157 Against Hepatitis B. Preclinical Data to be Presented at AASLD/EASL HBV Treatment Endpoints Workshop. Aug 2, 2016. Jul 28, 2016. Jul 20, 2016.
ir.contravir.com
Corporate Governance | ContraVir Pharmaceuticals
http://ir.contravir.com/corporate-governance
Press enter to begin your search. Corporate Governance involves the processes and procedures used to manage the business affairs of a company and includes the structure and balance of power between the management and board. This section provides bios of board and committee members, as well as charters and codes of conduct developed for the various committees. ContraVir Code of Business Conduct and Ethics. ContraVir Audit Committee Charter. ContraVir Compensation Committee Charter. Edison, NJ 08837.
SOCIAL ENGAGEMENT